menu
    • menu

    Company profile for Sumitomo Pharma America

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sumitomo Pharma America (SMPA) is committed to accelerating scientific and therapeutic breakthroughs on behalf of patients in critical disease areas across psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., ...
    Sumitomo Pharma America (SMPA) is committed to accelerating scientific and therapeutic breakthroughs on behalf of patients in critical disease areas across psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., Sumitomo Pharma Oncology, Inc., Sumitovant Biopharma, Inc., Myovant Sciences, Inc., Urovant Sciences, Inc., and Enzyvant Therapeutics, Inc. SMPA is a Sumitomo Pharma company.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sumitomo Pharma AmericaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    55 Cambridge Parkway Suite 102W Cambridge, MA 02142
    Telephone
    Telephone
    +1 5084816700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.us.sumitomo-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sumitomo-pharma-america/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/SumitomoPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sumitomo Pharma Unveils Promising Data on Leukemia, Myelofibrosis
    Sumitomo Pharma Unveils Promising Data on Leukemia, Myelofibrosis

    06 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/clinical-trials/sumitomo-pharma-america-unveils-promising-new-leukemia-and-myelofibrosis-data-ahead-of-ash-2025-18161

    INDPHARMAPOST
    06 Nov 2025
    Share Share
    Sumitomo Pharma America To Unveil New Data at ASH Meeting
    Sumitomo Pharma America To Unveil New Data at ASH Meeting

    03 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-america-to-present-new-investigational-data-at-the-2025-american-society-of-hematology-annual-meeting-302602334.html

    PR NEWSWIRE
    03 Nov 2025
    Share Share
    Sumitomo Pharma Presents New Vibegron Data at 2025 AUA Meeting
    Sumitomo Pharma Presents New Vibegron Data at 2025 AUA Meeting

    29 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-america-presents-new-data-on-vibegron-at-the-2025-american-urological-association-annual-meeting-302440736.html

    PR NEWSWIRE
    29 Apr 2025
    Share Share
    Foundation Medicine, Sumitomo Partner On Acute Leukemia Therapy
    Foundation Medicine, Sumitomo Partner On Acute Leukemia Therapy

    18 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250218523943/en

    BUSINESSWIRE
    18 Feb 2025
    Share Share
    Sumitomo Pharma Get Approval for Gemtesa in Overactive Bladder
    Sumitomo Pharma Get Approval for Gemtesa in Overactive Bladder

    23 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-america-announces-us-fda-approval-of-gemtesa-vibegron-for-men-with-overactive-bladder-symptoms-receiving-pharmacological-therapy-for-benign-prostatic-hyperplasia-302338114.html

    PR NEWSWIRE
    23 Dec 2024
    Share Share
    Sumitomo Pharma Presents Data on Nuvisertib and Enzomenib at ASH
    Sumitomo Pharma Presents Data on Nuvisertib and Enzomenib at ASH

    09 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-america-presents-new-data-on-nuvisertib-and-enzomenib-at-the-2024-american-society-of-hematology-annual-meeting-302326146.html

    PR NEWSWIRE
    09 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search